Epidemiology of

Campylobacter spp Campylobacter-related infection diarrhea immunodepression kidney transplant recipients

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Sep 2024
Historique:
received: 10 06 2024
accepted: 03 09 2024
medline: 19 9 2024
pubmed: 19 9 2024
entrez: 19 9 2024
Statut: epublish

Résumé

Campylobacteriosis in kidney transplant recipients (KTRs) is the most common identified bacterial cause of diarrhea. Risk factors in KTRs are unknown. A 10-year multicentric, retrospective 1:1 case-control study was performed in France between 2010 and 2020. The main aim was to identify factors associated with We identified 326 patients with campylobacteriosis. The estimated incidence rate of campylobacteriosis was 2.3/1000 patient-years. The infection occurred at a median of 2.4 years posttransplantation. The independent risk factors for campylobacteriosis were use of corticosteroids as maintenance regimen (75.8% vs 66%; Campylobacteriosis has a higher incidence in the 2 first years of transplantation. The factors independently associated with campylobacteriosis are corticosteroids as maintenance immunosuppressive regimen, low lymphocyte counts, low eGFR, and a history of acute rejection. Due to high antimicrobial resistance with fluoroquinolone, the first line of treatment should be azithromycin.

Sections du résumé

Background UNASSIGNED
Campylobacteriosis in kidney transplant recipients (KTRs) is the most common identified bacterial cause of diarrhea. Risk factors in KTRs are unknown.
Methods UNASSIGNED
A 10-year multicentric, retrospective 1:1 case-control study was performed in France between 2010 and 2020. The main aim was to identify factors associated with
Results UNASSIGNED
We identified 326 patients with campylobacteriosis. The estimated incidence rate of campylobacteriosis was 2.3/1000 patient-years. The infection occurred at a median of 2.4 years posttransplantation. The independent risk factors for campylobacteriosis were use of corticosteroids as maintenance regimen (75.8% vs 66%;
Conclusions UNASSIGNED
Campylobacteriosis has a higher incidence in the 2 first years of transplantation. The factors independently associated with campylobacteriosis are corticosteroids as maintenance immunosuppressive regimen, low lymphocyte counts, low eGFR, and a history of acute rejection. Due to high antimicrobial resistance with fluoroquinolone, the first line of treatment should be azithromycin.

Identifiants

pubmed: 39296338
doi: 10.1093/ofid/ofae498
pii: ofae498
pmc: PMC11409881
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofae498

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Déclaration de conflit d'intérêts

Potential conflicts of interest. The authors: No reported conflicts of interest.

Auteurs

Feline Bos (F)

Infectious and Tropical Diseases Department, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Department of Nephrology, Transplantation, Dialysis and Apheresis, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

Romain Gueneau (R)

Department of Infectious Diseases and Tropical Medicine, Assistance Publique-Hôpitaux de Paris, Necker-Enfants Malades University Hospital, Paris, France.

Thomas Crepin (T)

Department of Nephrology, Dialysis, and Renal Transplantation, Centre Hospitalier Universitaire Besançon, Besançon, France.

Claire Tinévez (C)

Infectious and Tropical Diseases Department, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

Benjamin Taton (B)

Department of Nephrology, Transplantation, Dialysis and Apheresis, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

Lionel Couzi (L)

Department of Nephrology, Transplantation, Dialysis and Apheresis, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

Karine Moreau (K)

Department of Nephrology, Transplantation, Dialysis and Apheresis, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

Betoul Schvartz (B)

Nephrology and Transplant Department, Centre Hospitalier Universitaire de Reims, Reims, France.

Peggy Perrin (P)

Nephrology-Transplantation Department, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France.

Philippe Gatault (P)

Nephrology-Transplantation Department, Centre Hospitalier Universitaire de Tours, Tours, France.

Anne Scemla (A)

Department of Infectious Diseases and Tropical Medicine, Assistance Publique-Hôpitaux de Paris, Necker-Enfants Malades University Hospital, Paris, France.

Valérie Chatelet-Pouliquen (V)

Nephrology-Transplantation Department, Centre Hospitalier Universitaire de Caen, Caen, France.

Charlène Levi (C)

Department of Transplantation, Centre Hospitalier Universitaire de Lyon-Est, Hospices Civils de Lyon, Edouard Herriot Hospital, Nephrology and Clinical Immunology, Lyon, France.

Nassim Kamar (N)

Department of Nephrology and Organ Transplantation, Toulouse Rangueil University Hospital, Institut national de la santé et de la recherche médicale, Unité mixte de recherche 1291, Toulouse Institute for Infectious and Inflammatory Diseases, University Paul Sabatier, Toulouse, France.

Fanny Lanternier (F)

Department of Infectious Diseases and Tropical Medicine, Assistance Publique-Hôpitaux de Paris, Necker-Enfants Malades University Hospital, Paris, France.

Didier Neau (D)

Infectious and Tropical Diseases Department, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

Pierre Merville (P)

Department of Nephrology, Transplantation, Dialysis and Apheresis, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

Philippe Lehours (P)

Bacteriology Department, Centre Hospitalier Universitaire de Bordeaux, National Reference Center for Campylobacter and Helicobacter, Bordeaux, France.
Institut national de la santé et de la recherche médicale, Université de Bordeaux, Unité mixte de recherche 1312, Bordeaux Institute of Oncology, Bordeaux, France.

Mathilde Puges (M)

Infectious and Tropical Diseases Department, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

Hannah Kaminski (H)

Department of Nephrology, Transplantation, Dialysis and Apheresis, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

Classifications MeSH